Peers Price Chg Day Year Date
Avita Medical 1.29 -0.08 -5.84% -50.19% Mar/09
Akebia Therapeutics 1.33 0.06 4.33% -28.76% Mar/09
Tectonic Therapeutic 33.27 -2.60 -7.25% 56.12% Mar/09
Clinuvel Pharmaceuticals 10.00 -0.16 -1.57% -15.61% Mar/09
Genetic Signatures 0.10 0 0% -81.37% Mar/09
Ionis Pharmaceuticals 74.13 0.09 0.12% 130.07% Mar/09
Dianthus Therapeutics 77.78 12.58 19.29% 219.56% Mar/09
Medical Developments International 0.42 -0.01 -2.33% -28.21% Mar/09
Neuren Pharmaceuticals 11.68 -0.67 -5.43% -3.71% Mar/09
Organon & Co 6.42 -0.15 -2.21% -59.19% Mar/09


Ecofibre Ltd traded at 0.02 this Thursday May 1st, decreasing 0.001 or 4.76 percent since the previous trading session. Looking back, over the last four weeks, Ecofibre lost 4.76 percent. Over the last 12 months, its price fell by 70.59 percent. Looking ahead, we forecast Ecofibre Ltd to be priced at 0.02 by the end of this quarter and at 0.02 in one year, according to Trading Economics global macro models projections and analysts expectations.

Ecofibre Limited is an advanced manufacturing and technology business focused on sustainable polymers and natural materials, natural health care, and hemp seed genetics. It also owns interest in a life sciences business that is developing treatments for malignant and non-malignant gynecological diseases. Its segments include Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, Ecofibre Corporate, and EOF Bio Inc. Ecofibre Advanced Technologies segment is engaged in advanced manufacturing business in performance yarn extrusion, polymer compounding and textiles manufactured in the United States. Ananda Health segment is engaged in the production and sale of hemp related and other nutraceutical products in the United States and Australia. Ecofibre Genetics segment is engaged in the supply of seed genetics to the hemp fiber and grain industry in the United States and Australia. Ecofibre Corporate segment is engaged in group corporate and shared service functions.